Northwestern Mutual Wealth Management’s Virtus Biotech ETF BBP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$314	–	3623
2024 Q3	$314	Buy	+5	New	+$311	﹤0.01%	3393
2023 Q3	–	Sell	-207	Closed	-$10.9K	–	3292
2023 Q2	$10.9K	Hold	207	–	–	﹤0.01%	2543
2023 Q1	$10.2K	Hold	207	–	–	﹤0.01%	2504
2022 Q4	$10.2K	Hold	207	–	–	﹤0.01%	2491
2022 Q3	$9K	Buy	+207	New	+$9.56K	﹤0.01%	2483
2019 Q3	–	Sell	-468	Closed	-$19K	–	2463
2019 Q2	$19K	Buy	+468	New	+$19.3K	﹤0.01%	1742

Other funds holding BBP

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JCM

Jag Capital Management St Louis, Missouri $889M AUM 42.63% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Northwestern Mutual Wealth Management's BBP Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of Virtus Biotech ETF (BBP) in Q4 2024, closing a stake of 5 shares — an estimated $314 sold.

Northwestern Mutual Wealth Management first reported a position in BBP in Q2 2019 and held it in 6 quarters. The position peaked at $19K in Q2 2019. 13 funds tracked by Wall St. Rank hold BBP as of Q4 2024.

Northwestern Mutual Wealth Management reported no remaining Virtus Biotech ETF position as of Q4 2024 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 5 Virtus Biotech ETF shares in Q4 2024, an estimated $314.
Northwestern Mutual Wealth Management first reported a position in Virtus Biotech ETF in Q2 2019 and held it in 6 quarters.
Northwestern Mutual Wealth Management's Virtus Biotech ETF position peaked at $19K in Q2 2019.
13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.